Sanofi SA (NASDAQ:SNY)
| 47.00 Delayed Data As of Feb 07 |  +1.11 / +2.42%Today’s Change | 36.91 Today|||52-Week Range 58.10 | -2.95% Year-to-Date |
Latest SNY News | Press Releases
| New Strong Buy Stocks for February 7th Feb 07 / Zacks.com - Paid Partner Content | Sanofi (SNY) Q4 Earnings Miss Estimates, Vaccine Sales Weak Feb 03 / Zacks.com - Paid Partner Content |
| Sanofi (SNY) Q4 2022 Earnings Call Transcript Feb 03 / MotleyFool.com - Paid Partner Content | Pharma Stock Roundup: MRK, LLY, PFE Q4 Results, J&J's Loss in Talc Lawsuits Feb 03 / Zacks.com - Paid Partner Content |
| Gilead (GILD) Q4 Earnings & Sales Top on Biktarvy & Oncology Feb 03 / Zacks.com - Paid Partner Content | Bristol-Myers (BMY) Q4 Earnings Top, Revlimid Generic Impact Sales Feb 02 / Zacks.com - Paid Partner Content |
| Chubb Ltd Buys 2, Sells 3 in 4th Quarter Feb 03 / GuruFocus News - Paid Partner Content | Roche's (RHHBY) 2022 Core Earnings Grow, 2023 Outlook Dismal Feb 02 / Zacks.com - Paid Partner Content |
| Regeneron (REGN) Q4 Earnings & Sales Beat, Eylea Sales Decline Feb 03 / Zacks.com - Paid Partner Content | Merck (MRK) Beats on Q4 Earnings & Sales, 2023 View Disappoints Feb 02 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 45.86 |
| Today’s open | 46.28 |
| Day’s range | 46.21 - 47.06 |
| Volume | 2,424,838 |
| Average volume (3 months) | 2,719,824 |
| Market cap | $115.3B |
Data as of 4:00pm ET, 02/07/2023
Growth & Valuation
| Earnings growth (last year) | -- |
| Earnings growth (this year) | +1.52% |
| Earnings growth (next 5 years) | +7.50% |
| Revenue growth (last year) | -- |
| P/E ratio | 17.2 |
| Price/Sales | 2.68 |
| Price/Book | -- |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| REGNRegeneron Pharmaceut... | -10.92 | -1.40% |
| VRTXVertex Pharmaceutica... | +3.67 | +1.20% |
| ZTSZoetis Inc | +0.64 | +0.39% |
| ---- |
Data as of 4:00pm ET, 02/07/2023
Financials
| Next reporting date | April 27, 2023 |
| EPS forecast (this quarter) | $1.10 |
| Annual revenue (last year) | -- |
| Annual profit (last year) | -- |
| Net profit margin | 15.63% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Paris, Ile-de-france |
Forecasts
